Atlas Trials

Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.

Clinical trial NCT00223938 · TERMINATED

Trial details

NCT number
NCT00223938
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Anemia
Start date
2003-12-30
Primary completion
2007-04-27
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.